Idebenone
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


Idebenone
Description:
Idebenone, a well-appreciated mitochondrial protectant, exhibits protective efficacy against neurotoxicity and can be used for the research of Alzheimer's disease, Huntington's disease. Idebenone (oxidised form) has a dose-dependent inhibitory effect on the enzymatic metabolism of arachidonic acid in astroglial homogenates (IC50=16.65 μM) [1]. Idebenone, a coenzyme Q10 analog and an antioxidant, induces apoptotic cell death in the human dopaminergic neuroblastoma SHSY-5Y cells[2]. Idebenone quickly crosses the blood-brain barrier.UNSPSC:
12352005Hazard Statement:
H302, H315, H319, H335Target:
Apoptosis; Mitochondrial MetabolismType:
Reference compoundRelated Pathways:
Apoptosis; Metabolic Enzyme/ProteaseApplications:
Neuroscience-NeurodegenerationField of Research:
Neurological DiseaseAssay Protocol:
https://www.medchemexpress.com/idebenone.htmlPurity:
99.84Solubility:
DMSO : ≥ 100 mg/mLSmiles:
O=C1C(CCCCCCCCCCO)=C(C)C(C(OC)=C1OC)=OMolecular Formula:
C19H30O5Molecular Weight:
338.44Precautions:
H302, H315, H319, H335References & Citations:
[1]G Civenni, et al. Inhibitory effect of the neuroprotective agent idebenone on arachidonic acid metabolism in astrocytes.Eur J Pharmacol. 1999 Apr 9;370 (2) :161-7.|[2]Kwok-Keung Tai, et al. Idebenone induces apoptotic cell death in the human dopaminergic neuroblastoma SHSY-5Y cells. Neurotox Res. 2011 Nov;20 (4) :321-8.Shipping Conditions:
Room TemperatureStorage Conditions:
-20°C, 3 years; 4°C, 2 years (Powder)Scientific Category:
Reference compound1Clinical Information:
LaunchedCAS Number:
[58186-27-9]
